Fluigent/ BEOnchip: a strategic partnership to better address the needs of the multidisciplinary field of organ on chip

Organs on chips are the next generation of in vitro models, more complex and physiologically relevant than traditional 2D cell culture. They aim to faithfully reproduce biochemical or biophysical features of the local environment at the cell scale. This multidisciplinary field calls on the expertise of people with knowledge of microfabrication, microfluidics, and biology. To fully address customer needs, BEOnChip and Fluigent have partnered to merge their core competencies and offer complete solutions combining innovative, robust, and easy to use chips with high-performance instruments:

• BEOnChip designs and markets Organ on chip and microfluidic devices for cell culture applications to create the next generation of in vitro testing platforms. These allow for the performance of experiments in vitro that were impossible or only possible in vivo before
• Fluigent is a world-leading company developing cutting edge microfluidic instruments. Injection, recirculation, perfusion, and sampling are all functions that can be combined and automated to perform any protocol.